Matsumori, Yasuhiko http://orcid.org/0000-0001-5852-0146
Komori, Mika http://orcid.org/0000-0003-1887-1296
Tanji, Yuka http://orcid.org/0000-0001-7850-1946
Ozeki, Akichika http://orcid.org/0000-0001-5510-4219
Sakai, Fumihiko http://orcid.org/0000-0001-9385-7991
Clinical trials referenced in this document:
Documents that mention this clinical trial
Lasmiditan for Patients with Migraine and Contraindications to Triptans: A Post Hoc Analysis
https://doi.org/10.1007/s40122-022-00388-8
Rapid Onset and Sustained Efficacy of Lasmiditan Among Japanese Patients with Migraine: Prespecified Analyses of a Randomized Controlled Trial
https://doi.org/10.1007/s40120-022-00403-2
Funding for this research was provided by:
Eli Lilly Japan
Daiichi-Sankyo
Article History
Received: 4 July 2022
Accepted: 25 August 2022
First Online: 22 September 2022